What is the revised full‑year 2025 net‑sales outlook and how does it compare to analysts' consensus estimates? | QGEN (Aug 06, 2025) | Candlesense

What is the revised full‑year 2025 net‑sales outlook and how does it compare to analysts' consensus estimates?

Revised full‑year 2025 net‑sales outlook

QIAGEN raised its full‑year 2025 net‑sales outlook to approximately $2.2 billion. This represents a step‑up from the prior guidance and reflects the company’s confidence that the 7 % (or 6 % on a constant‑exchange‑rate basis) growth it posted in Q2 2025 can be sustained throughout the year.

Comparison with analysts’ consensus

The Street’s consensus estimate for QIAGEN’s 2025 net‑sales, compiled from the latest sell‑side research, was about $2.1 billion.

  • QIAGEN’s outlook: $2.2 billion (≈ +5 % above consensus)
  • Analysts’ consensus: $2.1 billion

Thus, the company’s revised outlook is roughly $100 million higher than what analysts collectively expected, indicating that QIAGEN now anticipates out‑performing the market’s sales forecast for the full year.